SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-016888
Filing Date
2023-05-03
Accepted
2023-05-03 07:55:59
Documents
45
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q wve-20230331.htm   iXBRL 10-Q 1469200
2 EX-31.1 wve-ex31_1.htm EX-31 19951
3 EX-31.2 wve-ex31_2.htm EX-31 20346
4 EX-32 wve-ex32.htm EX-32 14866
5 GRAPHIC img56417703_0.jpg GRAPHIC 98426
6 GRAPHIC img56417703_1.jpg GRAPHIC 166484
  Complete submission text file 0000950170-23-016888.txt   4732879

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT wve-20230331_cal.xml EX-101.CAL 31890
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT wve-20230331_pre.xml EX-101.PRE 190672
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT wve-20230331.xsd EX-101.SCH 30403
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT wve-20230331_lab.xml EX-101.LAB 275140
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT wve-20230331_def.xml EX-101.DEF 114648
39 EXTRACTED XBRL INSTANCE DOCUMENT wve-20230331_htm.xml XML 341522
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37627 | Film No.: 23881723
SIC: 2834 Pharmaceutical Preparations